Literature DB >> 3905588

Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma.

R H Morrow.   

Abstract

Nearly all epidemiological characteristics of Burkitt's lymphoma (BL) can be explained on the basis of relationships of BL to the intensity of the host response to Plasmodium falciparum. The major epidemiological associations are: the high degree of geographic correlation between the incidence rate of BL and the intensity of P. falciparum transmission, both at a global level and within individual countries; the close correlation between the age incidence of BL and the age of acquiring maximum levels of antimalarial immunoglobulin; the relative protection from BL by residence in urban areas, where levels of malaria transmission are lower, compared with rural areas; the decline in BL incidence in areas where death rates due to malaria have declined and, within such areas, a differential decline in BL incidence in people making better use of health facilities; the older age of onset in patients who have migrated from low-intensity to high-intensity malaria areas as compared with patients born in the high-intensity areas - the higher absolute age-specific incidence rate in those above age ten in this immigrant group being consistent with the hypothesis that intense malaria infection and consequent host defence response serve as the major triggering event in the pathogenesis of the lymphoma; the inverse geographic correlation between the average age of onset of BL and the intensity of falciparum malaria infection. An inverse association of BL with sickle-cell trait (AS haemoglobin) would provide strong evidence for the role of intense falciparum malaria, but most studies to date have not achieved statistical significance. Time-space clustering and reports of seasonal variation in BL incidence would indicate that a precipitating factor operates over a relatively short time-span, at least in some areas. Combining the evidence concerning cytogenetics, Epstein-Barr virus (EBV) and falciparum malaria, the following three-phase model for the oncogenesis of BL could account for virtually all the currently known facts and be tested by further laboratory and field studies: Primary infection with EBV, perhaps early and intense, leads to the immortalization of large numbers of B lymphocytes. Severe falciparum malaria then leads to an intense host response with particular proliferation of the EBV-infected B lymphocytes. Finally, the great increase in the B lymphocytes provides a much higher statistical opportunity for the emergence of the cytogenetically abnormal BL cell.

Entities:  

Mesh:

Year:  1985        PMID: 3905588

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  25 in total

1.  Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.

Authors:  Mercy Guech-Ongey; Masanori Yagi; Nirianne Marie Q Palacpac; Benjamin Emmanuel; Ambrose O Talisuna; Kishor Bhatia; D Cristina Stefan; Robert J Biggar; Francis Nkrumah; Janet Neequaye; Takahiro Tougan; Toshihiro Horii; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

2.  Mapping urban malaria and diarrhea mortality in Accra, Ghana: evidence of vulnerabilities and implications for urban health policy.

Authors:  Julius N Fobil; Christian Levers; Tobia Lakes; Wibke Loag; Alexander Kraemer; Juergen May
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

3.  Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009.

Authors:  Peter Aka; Esther Kawira; Nestory Masalu; Benjamin Emmanuel; Glen Brubaker; Josiah Magatti; Sam M Mbulaiteye
Journal:  Pediatr Blood Cancer       Date:  2012-05-22       Impact factor: 3.167

Review 4.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

5.  Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.

Authors:  Ibrahim I Daud; Sidney Ogolla; Asito S Amolo; Eunice Namuyenga; Kenneth Simbiri; Elizabeth A Bukusi; Zipporah W Ng'ang'a; Robert Ploutz-Snyder; Peter O Sumba; Arlene Dent; Rosemary Rochford
Journal:  Matern Child Health J       Date:  2015-03

6.  African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers.

Authors:  Benjamin Emmanuel; Esther Kawira; Martin D Ogwang; Henry Wabinga; Josiah Magatti; Francis Nkrumah; Janet Neequaye; Kishor Bhatia; Glen Brubaker; Robert J Biggar; Sam M Mbulaiteye
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

Review 7.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

8.  Age-related heterogeneity of Burkitt lymphoma.

Authors:  Sam M Mbulaiteye; William F Anderson
Journal:  Br J Haematol       Date:  2016-07-29       Impact factor: 6.998

9.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

10.  Elevated serum levels of interleukin-6 in endemic Burkitt lymphoma in Ghana.

Authors:  Peter Aka; Benjamin Emmanuel; Maria Candida Vila; Amar Jariwala; Francis Nkrumah; Maria V Periago; Janet Neequaye; Christine Kiruthu; Paul H Levine; Robert J Biggar; Kishor Bhatia; Jeffrey M Bethony; Sam M Mbulaiteye
Journal:  Hematol Oncol       Date:  2014-01-06       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.